Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.09 Analyst target: $30.00 Upside: 870.87%
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
See the full interactive analysis & chart →Informational only — not investment advice.